|
August 13, 2024
Interim Report Q2 2024
|
|
|
|
|
May 23, 2024
Interim Report Q1 2024
|
|
|
|
|
April 24, 2024
Annual Report 2023
|
|
|
|
|
February 21, 2024
Year-end Report 2023
|
|
|
|
|
January, 2024
Presentation Calliditas at JPM
|
|
|
|
|
November, 2023
Corporate Presentation
|
|
|
|
|
November 7, 2023
Interim Report Q3 2023
|
|
|
|
|
August 17, 2023
Interim Report Q2 2023
|
|
|
|
|
June 16, 2023
European Renal Association (ERA) Congress 2023
|
|
|
|
|
May 16, 2023
Interim Report Q1 2023
|
|
|
|
|
April 26, 2023
Annual Report 2022
|
|
|
|
|
March 13, 2023
NefIgArd topline data - presentation
|
|
|
|
|
February 23, 2023
Year-end report 2022
|
|
|
|
|
December 14, 2022
A Look into Calliditas’ China Commercial Partner Everest Medicines
|
|
|
|
|
November 14, 2022
Interim Report Q3 2022
|
|
|
|
|
November 8, 2022
KOL Fireside Chat with Professor Richard Lafayette on the US IgAN Treatment Landscape
|
|
|
|
|
August 18, 2022
Interim Report Q2 2022
|
|
|
|
|
May 18, 2022
Interim Report Q1 2022
|
|
|
|
|
April 27, 2022
Annual report 2021
|
|
|
|
|
February 24, 2022
Year-end report 2021
|
|
|
|
|
December 16, 2021
FDA Approval – Investor Update
|
|
|
|
|
November 18, 2021
Interim Report Q3 2021
|
|
|
|
|
August 19, 2021
Interim Report Q2 2021
|
|
|
|
|
May 18, 2021
Interim Report Q1 2021
|
|
|
|
|
April 27, 2021
Annual Report 2020
|
|
|
|
|
March 10, 2021
KOL Perspectives: The Pathophysiology and Treatment of IgA Nephropathy in Clinical Practice
|
|
|
|
|
February 18, 2021
Year-end report 2020
|
|
|
|
|
November 12, 2020
Interim Report Q3 2020
|
|
|
|
|
November 9, 2020
Conference call on positive topline results from pivotal phase 3 NefIgArd trial
|
|
|
|
|
August 13, 2020
Interim Report Q2 2020
|
|
|
|
|
May 14, 2020
Interim Report Q1 2020
|
|
|
|
|
April 28, 2020
Annual Report 2019
|
|
|
|
|
February 14, 2020
Year-end report 2019
|
|
|
|
|
November 14, 2019
Interim Report Q3 2019
|
|
|
|
|
August 15, 2019
Interim Report Q2 2019
|
|
|
|
|
May 8, 2019
Interim Report Q1 2019
|
|
|
|
|
April 4, 2019
Annual Report 2018
|
|
|
|
|
February 7, 2019
Year-end report 2018
|
|
|
|
|
November 1, 2018
Interim Report Q3 2018
|
|
|
|
|
August 16, 2018
Interim Report Q2 2018
|
|
|
|
|
April 24, 2018
Annual Report 2017, in Swedish
|
|
|
|
|
June 30, 2017
Annual Report 2016, in Swedish
|
|
|
|
